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Shiga toxin producing Escherichia coli (STEC) are important foodborne pathogens
responsible for human illnesses. Cattle are a major reservoir that harbor the organism
in the hindgut and shed in the feces. Shiga toxins (Stx) are the primary virulence factors
associated with STEC illnesses. The two antigenically distinct Stx types, Stx1 and Stx2,
encoded by stx1 and stx2 genes, share approximately 56% amino acid sequence
identity. Genetic variants exist within Stx1 and Stx2 based on differences in amino acid
composition and in cytotoxicity. The objective of our study was to identify the stx subtypes
in strains of STEC serogroups, other than O157, isolated from cattle feces. Shiga toxin
gene carrying E. coli strains (n = 192), spanning 27 serogroups originating from cattle
(n= 170) and human (n= 22) sources, were utilized in the study. Shiga toxin genes were
amplified by PCR, sequenced, and nucleotide sequences were translated into amino acid
sequences using CLC main workbench software. Shiga toxin subtypes were identified
based on the amino acid motifs that define each subtype. Shiga toxin genotypes were
also identified at the nucleotide level by in silico restriction fragment length polymorphism
(RFLP). Of the total 192 STEC strains, 93 (48.4%) were positive for stx1 only, 43 (22.4%)
for stx2 only, and 56 (29.2%) for both stx1 and stx2. Among the 149 strains positive for
stx1, 132 (88.6%) were stx1a and 17 (11.4%) were stx1c. Shiga toxin 1a was the most
common subtype of stx1 among cattle (87.9%; 123/140) and human strains (100%;
9/9) of non-O157 serogroups. Of the total 99 strains positive for stx2, 79 were stx2a
(79.8%), 11 (11.1%) were stx2c, 12 (12.1%) were stx2d. Of the 170 strains originating
from cattle feces, 58 (34.1%) were stx2a subtype, 11 (6.5%) were stx2c subtype, and 11
were of subtype stx2d (6.5%). All but one of the human strains were positive for stx2a.
Three strains of cattle origin were positive for both stx2a and stx2d. In conclusion, a
number of non-O157 STEC serogroups harbored by cattle possess a wide variety of
Shiga toxin subtypes, with stx1a and stx2a being the most predominant stx subtypes
occurring individually or in combination. Cattle are a reservoir of a number of non-O157
STEC serogroups and information on the Shiga toxin subtypes is useful in assessing the
potential risk as human pathogens.
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INTRODUCTION
Shiga toxin producing Escherichia coli (STEC) are major
foodborne pathogens responsible for human illnesses,
characterized by non-bloody to bloody diarrhea, sometimes
leading to complications of hemolytic uremic syndrome (HUS),
particularly in children (Gyles, 2007). Escherichia coli O157:H7
is the major serotype responsible for many of the STEC illness
outbreaks in humans. However, there is increasing incidence
of outbreaks associated with non-O157 STEC in recent years,
particularly O26, O45, O103, O111, O121, and O145, referred to
as top six non-O157 STEC. According to FoodNet sites, incidence
of top six non-O157 STEC infections increased from 0.12 per
100,000 population in 2,000 to 0.95 per 100,000 population in
2010 (Gould et al., 2013). Non-O157 STEC associated illnesses
range from cases of sporadic to major outbreaks, and clinically,
from mild watery diarrhea to life threatening complications of
HUS, similar to STEC O157 infections (Johnson et al., 2006).
Cattle are a major reservoir of O157 and non-O157 STEC, which
harbor the organisms in the hindgut and shed in the feces.
Consumption of water, beef and fresh produce contaminated
with cattle feces leads to human illnesses. In addition to O157
and the six top non-O157, cattle do harbor and shed in the
feces a number of other serogroups of STEC (Bettelheim, 2007;
Hussein, 2007).
Shiga toxins (Stx) are the major virulence factors of STEC.
Shiga toxins (Stx) belong to the AB5 family of protein toxins,
with an enzymatically active A moiety and a B moiety involved
in binding to the host cell receptor. The A subunit is responsible
for the cleavage of N-glycosidic bond in the 28 s rRNA of 60 s
ribosomal subunit, which leads to cytotoxicity (Endo et al., 1988;
Fraser et al., 1994). The two antigenically distinct Stx types, Stx1
and Stx2, encoded by stx1 and stx2 genes, share approximately
56% amino acid sequence similarity (Strockbine et al., 1986;
Weinstein et al., 1988). Although Stx1 and Stx2 are structurally
similar, they differ in cellular distribution and cytotoxicity. Shiga
toxin 1 is located in the periplasmic space of the bacterial cell,
whereas Stx2 is in the extracellular fraction (Shimizu et al., 2009).
Basu et al. (2016) have shown that A1 subunit of Stx2 has a higher
affinity for ribosomes and a higher catalytic activity compared to
A1 subunit of Stx1 (Basu et al., 2016), which makes Stx2 more
cytotoxic than Stx1. Shiga toxin 2 is reported to be 400 timesmore
toxic than Stx1 in a murine infection model (Tesh et al., 1993).
Shiga toxin 2 is more commonly associated with complications
of HUS than Stx1 (Ethelberg et al., 2004; Brooks et al., 2005).
Variants exist within stx1 (stx1a, stx1c, and stx1d) and stx2
(stx2a, stx2b, stx2c, stx2d, stx2e, stx2f, and stx2g) families based
on differences in amino acid compositions and in the degree
of cytotoxicity. The outcome of human illness associated with
STEC strains has been shown to be influenced by Stx subtypes
(Friedrich et al., 2002). Shiga toxin 2a and Stx2c are the major
subtypes produced by E. coli O157:H7 strains associated with
HUS in humans (Persson et al., 2007). Therefore, identifying
the subtypes of (Stx) is important to assess the potential risk
for human illnesses associated with STEC infections. Subtyping
method based on restriction fragment length polymorphism of
PCR products (PCR-RFLP) has been developed to identify stx1
(stx1a, stx1c, and stx1d) and stx2 (stx2, stx2v-ha, stx2v-hb, stx2g,
stx2-NV206, and stx2-EC1586) genotypes at the nucleotide level
based on their unique restriction patterns (Gobius et al., 2003;
Beutin et al., 2007). However, the demerits of this method are the
lack of consistency in the nomenclature, and misinterpretation
of stx subtypes due to single nucleotide changes (Scheutz et al.,
2012). Scheutz et al. (2012) standardized the Stx nomenclature
by designating stx1 subtypes as stx1a, stx1c and stx1d, and stx2
subtypes as stx2a, stx2b, stx2c, stx2d, stx2e, stx2f, and stx2g based
on amino acid sequence similarity (Scheutz et al., 2012). There is
a paucity of data on Shiga toxin subtypes carried by non-O157 E.
coli serogroups isolated from cattle feces in the United States. The
objective of our study was to determine the subtypes of stx1 and
stx2 in non-O157 E. coli serogroups isolated from cattle feces.
MATERIALS AND METHODS
Strains
Shiga toxin gene-positive E. coli strains (n = 192) spanning
27 non-O157 E. coli serogroups isolated from cattle feces (n =
170), and human clinical cases (n = 22), available in our culture
collection, were used in the study. A majority of strains belonged
to the top six non-O157 E. coli serogroups: O26 (n= 16), O45 (n
= 4), O103 (n = 54), O111 (n = 21), O121 (n = 4), and O145
(n = 27). The other non-O157 E. coli serogroups included O6
(n = 2), O8 (n = 3), O15 (n = 1), O22 (n = 1), O38 (n = 2),
O39 (n = 3), O74 (n = 3), O88 (n = 3), O91 (n = 2), O96 (n =
3), O104 (n = 18), O113 (n = 3), O116 (n = 3), O117 (n = 3),
O130 (n = 4), O141 (n = 3), O146 (n = 1), O153 (n = 1), O163
(n = 2), O171 (n = 3), and O172 (n = 2). Cattle strains were
isolated from feces, primarily from commercial feedlots (Renter
et al., 2005; Noll et al., 2015; Shridhar et al., 2016; Cull et al.,
2017). A few human clinical strains, obtained from Michigan
State University (MSU) and the Kansas Department of Health
and Environment (KDHE), were also included in the study.
The strains, stored at −80◦ C on cryo beads (CryoCareTM, Key
Scientific Products, Round Rock, TX), were streaked onto blood
agar plates (Remel, Lenexa, KS), colonies were suspended in 50
µl distilled water, boiled for 10 min, centrifuged at 9,300 × g
for 5 min, and supernatant was used for PCR amplification and
subsequent sequencing of the amplicons.
Primers Design
Nucleotide sequences of stx1 and stx2 of E. coli O157 and
non-O157 E. coli were downloaded from NCBI Genbank. The
sequences were aligned using CLC Main Workbench (CLC Bio,
Cambridge, MA), and the conserved regions flanking the Shiga
toxin genes were selected to design the oligonucleotide primers
for amplification of stx1 and stx2 genes (Table 1). Sequences
of stx2f subtype appeared to be more divergent from the other
subtypes, therefore, a separate set of primers were designed for
amplification (Table 1). Primers were obtained from Integrated
DNA technologies (Coralville, Iowa).
PCR Assay Conditions
The stx genes were amplified by touchdown PCR method, where
the annealing temperature of each cycle was lowered gradually to
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TABLE 1 | Target genes, primers used and size of amplicons.
Target
gene
Primers Sequence Amplicon
size (bp)
Reference
stx1 Forward GCTCAAGGAGTATTGTGTAATATG 1,233 This study
Reverse TCGCTGAATCCCCYTC
stx2 Forward CGAATCCAGTACAACGC 1,390 This study
Reverse CCCACATACCACGAATC
stx2f Forward CGTCATTCACTGGTTGG 766 This study
Reverse GCTGAGCACTTTGTAACA
avoid amplification of non-specific sequences (Don et al., 1991).
PCR was performed using Eppendorf Mastercycler (Eppendorf,
Hamburg, Germany).
PCR amplification protocol for stx1 included an initial
denaturation at 94◦C for 5 min, 10 cycles of touch-down PCR
(denature: 94◦C for 30 s, annealing: 56–51◦C (1-0.5◦C) for 30
s; and extension: 72◦C for 1 min 45 s) followed by 30 cycles of
regular PCR (denature: 94◦C for 30 s, annealing: 51◦C for 30 s;
and extension: 72◦C for 1 min 45 s). PCR amplification protocol
for stx2 included an initial denaturation at 94◦C for 5 min, 10
cycles of touch-down PCR (denature: 94◦C for 30 s, annealing:
47–44◦C (1-0.3◦C) for 30 s; and extension: 72◦C for 1 min 45
s) followed by 30 cycles of regular PCR (denature: 94◦C for 30 s,
annealing: 44◦C for 30 s; and extension: 72◦C for 1 min 45 s). All
PCR reagents were obtained from TaKaRa Bio USA, Inc. (CA).
Sequencing and Data Analyses
Amplified PCR products were visualized using a Qiaxcel
capillary electrophoresis system (Qiagen, Valencia, CA) and
purified using a QIAquick PCR purification kit (Qiagen). The
purified PCR products were measured by a spectrophotometer
(NanoDrop-Thermo Scientific, Wilmington, DE) to assess the
DNA concentration and purity. PCR products and primers
were shipped to Genewiz, Inc., (South Plainfield, NJ) for
nucleotide sequencing. The chromatogram data were visualized
using the CLC Main Workbench software for further analysis.
All sequences were individually analyzed for conflicts, and
secondary peaks, and consensus sequences were produced.
Nucleotide sequences were translated to amino acid sequences
after removing intergenic sequences. Shiga toxin subtypes were
determined based on the amino acid motifs that define each stx
subtype (Scheutz et al., 2012).
In silico Restriction Fragment Length
Polymorphism (RFLP)
A subset of strains (n = 68) were subjected to in silico RFLP for
identification of stx1 (stx1, stx1c, and stx1d) and stx2 (stx2, stx2v-
ha, stx2v-hb, stx2-NV206, stx2g, and stx2-EC1586) genotypes.
For stx1, a 391–392 bp fragment starting with GAYTATCAT
GGACAAGACTCYGTT and ending with TGACGATACYTT
TACAGTTAAAGTGG was digested with RsaI, FokI, and NciI
enzymes using CLC Main Workbench software to identify the
unique restriction sites for each stx1 genotype. For stx2, a 270 bp
fragment starting with ATGAAGAAGATGTTTATG and ending
with CAGTTTAATAATGACTGA was digested with HaeIII,
RsaI, FokI, and NciI enzymes (Beutin et al., 2007) using CLC
Main Workbench software. Restriction patterns of stx1 and stx2
sequences of the non-O157 STEC strains were compared to that
of the reference sequences from the NCBI database to identify the
stx1 and stx2 genotypes.
Cloning and Sequencing of PCR Products
Three strains belonging to serogroups O96, O113, and O130
that revealed double peaks in the chromatograms of stx2
sequences were subjected to cloning. PCR products were cloned
using TOPO R© TA Cloning kits and protocols by Invitrogen-
Life Technologies (Grand Island, NY). Up to 12 transformants
were selected and grown in Luria Bertani broth (LB; Becton,
Dickinson Co., Sparks, MD) containing carbenicillin for 2 h.
Clones obtained from the LB broth were subjected to sequencing
using flanking M13 forward and reverse primers. The sequences
were analyzed as mentioned above to identify the Shiga toxin
subtypes.
RESULTS
Of the total 192 non-O157 STEC strains (170 cattle and 22 human
strains) belonging to 27 serogroups tested in the study, 93 (48.4%)
were positive for stx1 only, 43 (22.4%) for stx2 only, and 56
(29.2%) for both stx1 and stx2. A total of 149 strains belonging
to 23 serogroups were positive for stx1, and of those 132 (88.6%)
were stx1a and 17 (11.4%) were stx1c (Table 2). Of the 140 stx1
positive strains originating from cattle feces, 123 (87.9%) were
stx1a subtype, and 17 (12.1%) were stx1c. Shiga toxin 1a was the
only stx1 subtype found in human STEC strains (9/9; 100%). The
stx1a was also the most common subtype of stx1 identified in top
six non-O157 E. coli serogroups (Table 2). None of the strains
were positive for more than one stx1 subtype.
A total of 99 strains belonging to 25 serogroups were positive
for stx2, and of those 79 were stx2a (79.8%), 11 (11.1%)
were stx2c, 12 (12.1%) were stx2d. Three stx2 positive-strains
belonging to O96, O113 and O130 serogroups of cattle origin
revealed double peaks in the chromatogram of stx2 sequences,
suggesting the presence of more than one stx2 subtype in the
same strain. Subsequent cloning and sequencing revealed that all
three strains carried a combination of stx2a and stx2d. All human
clinical strains (n = 22), except one, were of subtype stx2a. Only
one strain belonging to serogroup O145 carried stx2d. All strains
positive for stx2c were of bovine origin (Table 2, Figure 1). Shiga
toxin subtypes 2e, 2f, and 2g were not detected in any of the
strains tested. A majority of cattle strains (n = 170) possessed
stx1a subtype (123/170; 72.4%) followed by stx2a (58/170; 34.1%;
Figure 1). However, a majority of human strains carried stx2a
(21/22; 95.5%) followed by stx1a (9/22; 40.9%). Shiga toxin 1a
was most commonly found in combination with stx2a in strains
(n = 46) belonging to 18 serogroups. Six strains belonging to
O8, O103, O117, and O130 carried a combination of stx1a and
stx2d. Two strains of serogroup O74 carried a combination of
stx1a and stx2c and a strain of serogroup O15 was positive for
a combination of stx1c and stx2c. A strain of serogroup O130 was
positive for three subtypes, stx1a, stx2a, and stx2d (Table 2).
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TABLE 2 | Shiga toxin subtype distribution in non-O157 Shiga toxin-producing E. coli (STEC) serogroups of cattle and human origin (n = 192).
Serogroup Cattle (n = 170) Human (n = 22)
stx1a stx1c stx2a stx2c stx2d stx1a stx1c stx2a stx2c stx2d
TOP NON-O157 STEC (N = 126)
O26 (n = 16) 9 3 2 4 (2a)
O45 (n = 4) 4
O103 (n = 54) 54 1 (1b)
O111 (n = 21) 14 13 (13a) 6 7 (6a)
O121 (n = 4) 4
O145 (n = 27) 11 8 (1a) 4 1 1 3 (1a) 1
Total 92 0 24 4 2 9 0 18 0 1
OTHER NON-O157 STEC (N = 66)
O6 (n = 2) 1 1 (1a) 1
O8 (n = 3) 3 1 (1a) 2 (2b)
O15 (n = 1) 1 1 (1c)
O22 (n = 1) 1 1 (1a)
O38 (n = 2) 1 2 (1a)
O39 (n = 3) 3
O74 (n = 3) 3 1 (1a) 2 (2d)
O88 (n = 3) 3 3 (3a)
O91 (n = 2) 1 2 (1a)
O96 (n = 3) 2 3 (2a) 1 (1e)
O104 (n = 18) 16 2
O113 (n = 3) 2 (1e) 2
O116 (n = 3) 3 3 (3a)
O117 (n = 3) 2 1 2 (2b)
O130 (n = 4) 3 2 (1a) 2 (1b,1f ) 1
O141 (n = 3) 3 3 (3a)
O146 (n = 1) 1 1 (1a)
O153 (n = 1) 1 1 (1a)
O163 (n = 2) 2 2 (2a)
O171 (n = 3) 1 1 (1a) 2
O172 (n = 2) 2
Total 31 17 34 7 9 0 0 3 0 0
aContains strains positive for both stx1a and stx2a.
bContains strains positive for both stx1a and stx2d.
cContains strains positive for both stx1c and stx2c.
dContains strains positive for both stx1a and stx2c.
eContains strains positive for both stx2a and stx2d.
fContains strains positive for stx1a, stx2a and stx2d.
Numbers in the parenthesis indicate the presence of multiple stx subtypes.
The sequences from a subset of strains (n = 68) were
also analyzed by in silico RFLP. The sizes of fragments
generated by restriction enzyme digestion are shown in
Table 3. The two stx1 genotypes (stx1 and stx1c) determined
by in silico RFLP corresponded to the two subtypes (stx1a
and stx1c) determined based on the amino acid motifs. For
stx2, genotypes, such as stx2, stx2-NV206, and stx2v-ha
determined based on the restriction patterns corresponded
to stx2a, stx2d, and stx2c subtypes, respectively, determined
based on amino acid sequence. However, some strains
positive for stx2v-hb gene (based on restriction patterns)
corresponded to stx2c and some to stx2d subtype (based on
amino acid sequence motifs). Restriction patterns of stx1 and
stx2 genotypes determined by in silico RFLP are shown in
Figure 2.
DISCUSSION
Shiga toxins are the major virulence factors of STEC, which are
responsible for foodborne illnesses, including life threatening
complications of HUS in humans. Shiga toxins exist as several
subtypes, which vary in their cytotoxicity, and therefore in the
extent of their involvement in human illness (Friedrich et al.,
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FIGURE 1 | Percentage of stx1 and stx2 subtypes in non-O157 Shiga
toxin-producing Escherichia coli (STEC) strains isolated from cattle
(n = 170).
TABLE 3 | Restriction fragments of stx1 and stx2 genotypes based on
in silico RFLP.
Shiga toxin subtypes Restriction enzymes
HaeIII RsaI FokI NciI
Size(s) of restriction fragments (bp)
stx1 – 391 202, 189 391
stx1c – 267, 125 203, 189 241, 151
stx2 270 219, 51 155, 115 270
stx2v-ha 143, 127 139, 80, 51 270 270
stx2v-hb 143, 127 219, 51 270 141, 129
stx2-NV206 270 219, 51 270 141, 129
2002; Persson et al., 2007; Fuller et al., 2011). Fuller et al.
(2011) demonstrated that stx2a and stx2d subtypes were more
potent than stx2b, stx2c, and stx1 based on in vitro (using
primary human renal proximal tubule epithelial cells and Vero
cells) and in vivo (using mice) experiments (Fuller et al., 2011).
Karve and Weiss (2014) demonstrated stronger binding of stx2a,
stx2c, and stx2d to a mixture of Gb3 and glycolipids when
compared to stx1 and stx2b. Determining the Shiga toxin subtype
carried by the STEC strains is important to estimate the risk
of human illness associated with specific serotype or source of
transmission. Studies have shown that STEC strains carrying
stx2a and stx2c are most commonly associated with HUS in
humans (Friedrich et al., 2002; Persson et al., 2007; Iyoda et al.,
2014). Production of elastase activatable Stx2d subtype in STEC
strains has been reported to be a predictor of severity of clinical
illness (Bielaszewska et al., 2006). The cleavage of C-terminal
amino acids of A2 peptide of Stx2d by elastase has been reported
to increase the cytotoxicity of this Shiga toxin subtype (Kokai-
Kun et al., 2000; Melton-Celsa et al., 2002). The Stx2e subtype
is most commonly associated with porcine STEC, however, it
is also associated with STEC from asymptomatic humans and
fresh produce (Friedrich et al., 2002; Beutin et al., 2008; Feng
and Reddy, 2013). Although pigeons are a primary reservoir of
stx2f carrying E. coli strains, this subtype has also been isolated
from human diarrheic patients (Schmidt et al., 2000; Prager
et al., 2009). There are studies reporting the distribution of Shiga
toxin subtypes in STEC strains isolated from humans and fresh
produce (Friedrich et al., 2002; Feng and Reddy, 2013). There are
very limited studies on the distribution of Shiga toxin subtypes in
cattle, particularly of non-O157 serogroups, in the United States.
In this study, we identified Shiga toxin subtypes associated
with 27 serogroups of non-O157 STEC strains of cattle (n =
170) and human (n = 22) origin based on the amino acid
sequences deduced from nucleotide sequences. Additionally, we
also identified stx genotypes by in silico RFLP, based on the
restriction patterns obtained after in silico digestion of nucleotide
sequences with specific restriction enzymes. The most common
subtype of stx1 carried by non-O157 STEC strains of cattle and
human origin was stx1a. A similar finding was also reported in a
study on cattle and human STEC strains in Canada (Chui et al.,
2015). Tostes et al. (2017) reported that stx1a and stx2a are the
most common subtypes in both E. coli O157 and non-O157 E.
coli strains of human and bovine origin in Alberta (Tostes et al.,
2017). In the present study, a majority of the cattle STEC strains
(21.8%; 37/170) and human STEC strains (40.9%; 9/22) carried a
combination of stx1a and stx2a. A majority of E. coli O157:H7
strains isolated from outbreaks and sporadic cases in Canada
carried a combination of stx1a and stx2a (Chui et al., 2015). In
our study, 17 (10%) cattle STEC strains carried stx1c, while none
of the human STEC strains carried this subtype. STEC strains
carrying stx1c have been isolated from asymptomatic humans
and patients with uncomplicated diarrhea (Friedrich et al., 2003).
However, stx1c carrying E. coli O78 was isolated from a 2-
week old boy suffering from bacteremia and HUS in Finland
(Lienemann et al., 2012).
Shiga toxin subtype 2a was the most common stx2 subtype
(41.1%; 79/192) found in cattle and human sources. It was the
most common subtype detected in STEC strains isolated from
patients suffering from HUS (Persson et al., 2007) and those
isolated from fresh produce (Feng and Reddy, 2013). It was also
the most common subtype of stx2 in STEC strains isolated from
cattle in Australia (Brett et al., 2003) and France (Bertin et al.,
2001). The second most frequent subtype of stx2 associated with
STEC strains isolated from cattle was stx2c, however, none of the
human STEC strains included in this study contained stx2c. The
stx2c subtype has been reported in STEC strains isolated from
human patients suffering from HUS (Persson et al., 2007). It
was the third most common subtype (next to stx2d) associated
with STEC strains isolated from fresh produce (Feng and Reddy,
2013). Tostes et al. (2017) have reported the distribution of stx1
and stx2 subtypes associated with E. coli O157 and non-O157
E. coli serogroups of bovine and human origin in Alberta, and
found that the stx2c subtype was found only in E. coli O157
strains (Tostes et al., 2017). Shiga toxin 2c was the most common
subtype associated with STEC O157 strains of cattle origin in
Italy, however, none of the STEC O157 strains harbored stx2a
(Bonardi et al., 2015). However, in our study, 6.5% of the non-
O157 STEC strains isolated from cattle carried stx2c subtype. In
the present study, only a small proportion (6.5%) of the bovine
strains carried stx2d subtype, and only one human STEC strain
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FIGURE 2 | In silico restriction fragment length polymorphism (RFLP) of stx1 and stx2 genes of non-O157 Shiga toxin-producing Escherichia coli
(STEC) strains. (A) RFLP pattern of stx1a of a non-O157 STEC strain (O103 serogroup) isolated from cattle feces; (B) RFLP pattern of stx1c of a non-O157 STEC
strain (O15 serogroup) isolated from cattle feces; (C) RFLP pattern of stx2 of a non-O157 STEC strain (O145 serogroup) isolated from cattle feces.
carried stx2d. Tasara et al. (2008) have reported stx2d carrying
STEC strains isolated from cattle and sheep (Tasara et al., 2008).
Presence of stx2d carrying STEC strains in human patients was
reported to be significantly associated with HUS (Bielaszewska
et al., 2006). In our study, three cattle strains carried two different
stx2 subtypes (stx2a and stx2d). STEC strains carrying more than
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one stx2 subtypes have been reported in previous studies (Persson
et al., 2007; Scheutz et al., 2012). The significance of multiple stx2
subtypes with regard to virulence of STEC has not been studied
yet. The presence of multiple stx subtypes in STEC is assumed to
be the result of recombination of stx phages (Ashton, 2015).
We also identified Shiga toxin genotypes by in silico RFLP.
Some strains positive for stx2v-hb gene (based on restriction
patterns; Beutin et al., 2007) corresponded to stx2c and some
to stx2d subtype (based on amino acid sequence motifs).
Single nucleotide changes within the restriction sites could lead
to misinterpretation of stx subtypes based on the restriction
pattern (Scheutz et al., 2012). In conclusion, a number of non-
O157 STEC serogroups isolated from cattle possessed a wide
variety of Shiga toxin subtypes, with stx1a and stx2a being
the most predominant stx subtypes occurring individually or
in combination. Cattle harbor a number of non-O157 STEC
serogroups and identification of the Shiga toxin subtypes is useful
in assessing the potential risk to cause human illnesses.
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